Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProbeTILity: CC-38 in Metastatic Colorectal or Prostate Cancer
NCT07255664Phase 2Recruiting
- Sponsor
- CuraCell
- Start
- Nov 2025
- Primary completion
- Apr 2027
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CC-38 in colorectal cancer (CRC), prostate cancer (PCa), sponsored by CuraCell. Started Nov 2025; status: recruiting.
02
Drugs
CC-38
03
Conditions
colorectal cancer (CRC)prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07255664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07255664.